Our work primarily focuses on lung, esophageal, and head and neck cancers,
aiming to bridge the gap between scientific discovery and patient care.

We achieve this through comprehensive biomarker elucidation, cutting-edge genomic studies including single-cell and spatial transcriptomics, and the development of investigator-initiated trials.

 Furthermore, we are committed to improving patient quality of life through studies leveraging
wearable device-based technologies.

We invite you to explore our research and learn more about our contributions to cancer research.